AstraZeneca PLC (JOBS) Wins US Ban on Generic of Asthma Drug
Reuters -- A U.S. court has granted an injunction that bars Apotex from selling a generic version of AstraZeneca's lucrative Pulmicort Respules asthma medicine prior to a patent infringement trial, the British drugmaker said on Wednesday.